Scleritis Market Size, Share, Growth Report 2023-3029

The global scleritis market size was valued at USD x billion in 2021 and is poised to grow at a significant CAGR of 5.8% during the forecast period 2023-29. The primary drivers of the expansion of the global scleritis market include the increasing prevalence of scleritis, the growing geriatric population, developing healthcare infrastructure in economic countries, and technological advancements in treatment and diagnosis. The global scleritis market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In Mar 2022, U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma